Literature DB >> 8700521

Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.

D Rodenhiser1, P Chakraborty, J Andrews, P Ainsworth, D Mancini, E Lopes, S Singh.   

Abstract

Heterogeneous mutations in the BRCA1 tumour suppressor gene are responsible for a large percentage of inherited breast cancers as well as breast/ovarian cancers in families with a high incidence of both cancer types. Over a hundred BRCA1 mutations have been reported, but little is known of the mechanism(s) responsible for BRCA1 mutagenesis. To determine the significance of specific nucleotide sequences at mutational sites within the BRCA1 gene, we assessed how frequently independent BRCA1 mutations occur at the site of short direct repeats, single nucleotide repeats (homonucleotides) and at CpG and CpNpG motifs. We found that homonucleotide and short direct repeats are commonly associated with small deletions and insertions. Substitution mutations are frequently associated with homonucleotide repeats and with methylatable CpG dinucleotides and CpNpG trinucleotides. Our methylation and sequencing experiments show that CpG and certain CpNpG motifs are methylated, supporting the hypothesis that DNA methylation specificity at these sites may be an important contributor to BRCA1 mutagenesis. We suggest that BRCA1 mutations are acquired by replication errors and are retained by cells through an intricate balancing of replication and repair mechanisms. Such mutations may provide a proliferative advantage for a cell, leading to the tumour phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700521

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor.

Authors:  E Gomez-Lucia; Y Zhi; M Nabavi; W Zhang; D Kabat; M E Hoatlin
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Clinical and genetic studies of Birt-Hogg-Dubé syndrome.

Authors:  S K Khoo; S Giraud; K Kahnoski; J Chen; O Motorna; R Nickolov; O Binet; D Lambert; J Friedel; R Lévy; S Ferlicot; P Wolkenstein; P Hammel; U Bergerheim; M-A Hedblad; M Bradley; B T Teh; M Nordenskjöld; S Richard
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

4.  Sequence variation in the Fanconi anemia gene FAA.

Authors:  O Levran; T Erlich; N Magdalena; J J Gregory; S D Batish; P C Verlander; A D Auerbach
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).

Authors:  D Mancini; S Singh; P Ainsworth; D Rodenhiser
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

6.  Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes.

Authors:  M Krawczak; E V Ball; D N Cooper
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  The RB1 gene mutation in a child with ectopic intracranial retinoblastoma.

Authors:  Z Onadim; A J Woolford; J E Kingston; J L Hungerford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.